development of morphine agonists and antagonists
TRANSCRIPT
![Page 1: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/1.jpg)
DEVELOPMENT OF MORPHINE AGONISTS AND
ANTAGONISTSPresented by
Tejaswi.G University College Of
TechnologyOsmania University
![Page 2: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/2.jpg)
CONTENTS Introduction History Classification Structure of Morphine Mechanism of action Chemistry of Morphine Structure Activity Relationship Development of Morphine Analogueso Agonisto Antagonist Uses of Morphine Conclusion References
![Page 3: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/3.jpg)
INTRODUCTION
• ANALGESIC- A drug that selectively relieves pain by acting in the CNS or on peripheral mechanism without significantly altering consciousness .
• OPIOID ANALGESICS are also known as narcotic analgesics, that act on CNS, usually used for the treatment of acute and chronic pain, for thousands of years.
• OPIUM, a dark brown resinous material from unripe seeds of Poppy.
![Page 4: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/4.jpg)
HISTORY
• The writings of Theophrastus around 200BC describe the use of opium in medicine ; however evidence suggests that the opium is used in Sumerian cultures early as 3500BC. The initial use of opium was as a tonic, or it was smoked.
![Page 5: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/5.jpg)
• The pharmacist Surterner first isolated an alkaloid from opium in 1803.He named it as MORPHINE, after MORPHEUS, the Greek God Of Dreams.
![Page 6: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/6.jpg)
• Codeine, Thebaine and papavareine are other medicinally important alkaloids that were later isolated from latex of opium poppy.
• Morphine was among the first compounds to undergo structure modification.
• Ethyl morphine was introduced as a medicine in 1898.
• Diacetyl morphine(Heroin)which may be considered to be the first synthetic prodrug, was synthesized in 1874 and marketed as a non-addicting analgesic, anti-diarrheal and anti tussive agent in 1898.
![Page 7: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/7.jpg)
CLASSIFICATION OF OPIOIDS
![Page 8: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/8.jpg)
MORPHINE
• Morphine is the principal alkaloid in opium and still widely used. Therefore it is describe as prototype.Biological Source: It is obtained from
the juice or latex from the
unripe seed pods of the Papaver somniferum.
Family : Papavaraceae
![Page 9: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/9.jpg)
Structure Of Morphine
3D Structure
2D Structure
![Page 10: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/10.jpg)
MECHANISM OF ACTION• As morphine binds to opioid receptors,
molecular signalling activates the receptors to mediate certain actions.
• There are three important classes of opioid receptors and these are:
• μ receptor or Mu receptors - There are three subtypes of this receptor, the μ1, μ2 and μ3 receptors. Present in the brainstem and the thalamus, activation of these receptors can result in pain relief, sedation and euphoria as well as respiratory depression, constipation and physical dependence.
• κ receptor or kappa receptor - This receptor is present in the limbic system, part of the forebrain called the diencephalon, the brain stem and spinal cord. Activation of this receptor causes pain relief, sedation, loss of breath and dependence.
• δ receptor or delta - This receptor is widely distributed in the brain and also present in the spinal cord and digestive tract. Stimulation of this receptor leads to analgesic as well as antidepressant effects but may also cause respiratory depression.
![Page 11: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/11.jpg)
![Page 12: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/12.jpg)
![Page 13: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/13.jpg)
Structure activity Relationship Of
Morphine
![Page 14: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/14.jpg)
STRUCTURE
![Page 15: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/15.jpg)
STRUCTURE
![Page 16: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/16.jpg)
STRUCTURE
![Page 17: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/17.jpg)
STRUCTURE
![Page 18: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/18.jpg)
![Page 19: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/19.jpg)
![Page 20: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/20.jpg)
![Page 21: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/21.jpg)
![Page 22: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/22.jpg)
![Page 23: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/23.jpg)
![Page 24: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/24.jpg)
![Page 25: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/25.jpg)
![Page 26: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/26.jpg)
![Page 27: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/27.jpg)
![Page 28: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/28.jpg)
![Page 29: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/29.jpg)
Agent class Example Action
Agonist• Morphine• fentanyl• pethidine
activation of all receptor subclasses, though, with different affinities
Antagonist naloxone devoid of activity at all receptor classes
Agonist-Antagonist
nalorphine pentazocine
agonist activity at one type and antagonist activity at another
Partial Agonist buprenorphine activity at one or more, but not all receptor types
On the basis of these receptors, drugs can be divided into four groups. a. agonists b. antagonists c. agonist-antagonists d. partial agonists
![Page 30: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/30.jpg)
Morphine Sulfate
• Morphine sulfate is the analgesic used most often for severe,acute,and chronic pain. It is available in intramuscular,subcutaneous,oral,rectal and intrathecal dosage forms.
• 3-6 times more potent when given intramuscularly than when given orally.
• Half life -3hrs(intra muscular)
![Page 31: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/31.jpg)
Codeine Phosphate
• It is weak µ agonist, methyl ether of morphine.
• Activity:20% that of Morphine• Half Life: 3.5hrs• Treats: moderate pain, cough, diarrhoea.• Trade name:PANADOL
![Page 32: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/32.jpg)
Hydromorphone Hydrochloride
• Activity: potent µ agonist,(8 times greater than morphine)
• Half life : 2.5hrs(Parenteral)• 4hrs(oral)• Trade Name: Dilaudid
![Page 33: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/33.jpg)
Oxymorphone Hydrochloride
Activity: potent µ agonist,(10 times greater than morphine)
• Half life:3-4hrs• Treats: moderate to severe pain• Because of its 14-hydroxy group, has low
antitussive activity.• Trade Name: Numorphan
![Page 34: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/34.jpg)
Oxycodone Hydrochloride
• Activity: it is about equipotent with morphine
• Half life: 4hrs• Treats: Moderate to severe pain• Trade Name: Oxycontin,Percodan
![Page 35: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/35.jpg)
Meperidine Hydrochloride
• Activity:It is µ agonist having 1/10th of potency of Morphine
• Half life:3-4hrs• Treats:extensively used in Obstrics,when
given I.V respiratory depression of newborn child is minimised.
• Trade name:Demerol
![Page 36: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/36.jpg)
Fentanyl Citrate
• Activity:it is µ agonist and 80times greater potency than morphine
• Treats:Fentanyl patch is used for chronic pain.Used in combination with Nitrous oxide for balanced anaesthesia.
• Trade Name:DUROGESIC
![Page 37: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/37.jpg)
Buprenorphine Hydrochloride
• Activity:20-50 times more potent than morphine,partial agonist at µ,k receptors, receptors but antagonises at ð receptors.
• Treats: treatment of those addicted to opioids, such as heroin and oxycodon, but it may also be used to treat pain.
• Trade Name:Suboxone
![Page 38: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/38.jpg)
Pentazocine
• Activity:It is Weak antagonist (1/30th potency of naloxone),at receptors and agonist at k receptors.
• Treats: used to relieve moderate to severe pain. It may also be used before surgery or with a general anesthetic.
• Trade Name:Talwin
![Page 39: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/39.jpg)
Naloxone
• Activity: it is a pure opioid antagonist.• Treats:It is drug of choice for treating
Opioid respiratory and CVS depression• Trade name:Narcan
![Page 40: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/40.jpg)
Nalbuphine Hydrochloride
• Activity: It is an antagonist at receptors and an agonist at k receptors.
• Treats: Morphine Poisoning, severe to moderate pain.
• Trade name: Nubain
![Page 41: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/41.jpg)
![Page 42: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/42.jpg)
![Page 43: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/43.jpg)
![Page 44: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/44.jpg)
![Page 45: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/45.jpg)
![Page 46: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/46.jpg)
Before Addiction After Addiction
![Page 47: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/47.jpg)
CONCLUSION Finally we conclude that Morphine structure has
phenanthrene nucleus. Removal of 3-OH group reduces analgesic
activity. Acetylation of 3-OH and 6-OH group produces
very potent lipophilic compound. 6-OH and 7,8 double bond is not required for the
analgesic activity,elimination enhances the activity.
N-Methyl group substitution with larger alkyl groups reduces the activity.Substitution with larger araalkyl group increases the activity.
N-Methyl group replacement with alkyl,methyl cyclopropyl group - antagonist activity.
![Page 48: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/48.jpg)
REFERENCES
• An Introduction to Medicinal Chemistry –• Graham L. Patrick, 4th Edition.• Organic Chemistry Natural Products – O.PAgarwal, Volume – 1.• /www.drugbank.ca/ • https://en.wikipedia.org/wiki/Morphine
![Page 49: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/49.jpg)
![Page 50: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/50.jpg)
![Page 51: Development of morphine agonists and antagonists](https://reader036.vdocument.in/reader036/viewer/2022062412/5876bdda1a28abad1a8b74eb/html5/thumbnails/51.jpg)